Sol J Barer has an estimated net worth of $191 Million. This is based on reported shares across multiple companies, which include TEVA PHARMACEUTICAL INDUSTRIES LTD, AMICUS THERAPEUTICS INC, NexImmune, Inc., InspireMD, Inc., CONTRAFECT Corp, Edge Therapeutics, Inc., RestorGenex Corp, Cerecor Inc., CELGENE CORP /DE/, Aevi Genomic Medicine, Inc., and Aegerion Pharmaceuticals, Inc..
2005 was Sol J Barer's most active year for acquiring shares with 24 total transactions. Sol J Barer's most active month to acquire stocks was the month of May. 2006 was Sol J Barer's most active year for disposing of shares, totalling 22 transactions. Sol J Barer's most active month to dispose stocks was the month of May. 2016 saw Sol J Barer paying a total of $111,848,889.33 for 4,910,103 shares, this is the most they've acquired in one year. In 2009 Sol J Barer cashed out on 1,200,000 shares for a total of $31,274,460.00, their largest year based on trade value.